SABSWNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Market cap
$1.356 M
$0.01 +6.43%
Close of 22 Sept 2026
Revenue
$0.00
#3637 by revenue
Earnings
$13.3M
#1990 by earnings
Shares outstanding
90,986,368
Latest filing cover page
P/E ratio
0.1
Cap ÷ net income
Other share classes
SAB Biotherapeutics lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for SAB Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.